Gut Microbiota in Mood Disorders in Lebanese Population

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Gut MicrobiomeMood Disorders
Interventions
DRUG

Cerebiome

Evaluate the effect of oral intake of a probiotic agent on plasma inflammatory markers, gut bacterial profile and depressive state in a subgroup of target patients versus a subgroup treated with placebo

DRUG

Placebo

Placebo effect: Evaluate the effect of oral intake of a placebo, on clinical and plasma inflammatory markers, in a subgroup treated with placebo, in combination with conventional treatment for 12 weeks

Trial Locations (1)

Unknown

Saint-Joseph University, Beirut

All Listed Sponsors
collaborator

Lallemand Health Solutions, Canada

UNKNOWN

lead

St Joseph University, Beirut, Lebanon

OTHER

NCT05646784 - Gut Microbiota in Mood Disorders in Lebanese Population | Biotech Hunter | Biotech Hunter